RT Journal Article
SR Electronic
T1 The Forgotten Tract of Vision in Multiple Sclerosis: Vertical Occipital Fasciculus, Its Integrity, and Visuospatial Memory
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.25.21250430
DO 10.1101/2021.01.25.21250430
A1 AmirHussein Abdoalizadeh
A1 Soheil Mohammadi
A1 Mohammad Hadi Aarabi
YR 2021
UL http://medrxiv.org/content/early/2021/01/26/2021.01.25.21250430.abstract
AB Background Visual disturbances are a common disease manifestation and a major patient complaint in Multiple Sclerosis (MS) due to lesions damaging white matter tracts involved in vision. Vertical Occipital Fasciculus (VOF) connects ventral and dorsal visual streams and was neglected for more than a century. It has recently become under focus in brain-related disorders. Thus, its role in the visual dysfunction in MS needs to be clarified.Objective Evaluate the integrity of bilateral VOFs in MS and its association with clinical and visual evaluations.Methods 56 relapsing-remitting MS (RRMS) and 25 healthy controls (HC) were recruited. We acquired MS Functional Composite, Expanded Disability Status Scale (EDSS), and Brief Visuospatial Memory Test – Revised (BVMT-R), and structural and diffusion MRI scans. After VOF tractography, its integrity markers were statistically tested for between-group differences and clinical and visual tests associations.Results RRMS patients had lower fiber integrity in bilateral VOFs compared to HC. Lower integrity of bilateral VOFs was associated with poor clinical outcomes, higher visual score in EDSS, and lower total immediate and delayed recall in BVMT-R.Conclusion VOF damage is seen in RRMS and is associated with visual symptoms and visuospatial learning impairments.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBrainlife.io is supported by NSF BCS-1734853, NSF BCS-1636893, NSF ACI-1916518, NSF IIS-1912270, and NIH NIBIB-R01EB029272. The CRIMSON project was funded by Tehran University of Medical Sciences and the Iranian MS Society, Tehran, Iran. The authors did not receive funding to run the current project from any third-party.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We used the CRIMSON dataset comprising anonymized patient data. The CRIMSON dataset had IRB approval from Tehran University of Medical Sciences, Tehran, Iran.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe imaging analysis pipeline of this project is based on the cloud computing platform brainlife.io which can be accessed upon request. Moreover, the codes used to run the analysis on R are available upon request from the corresponding author. The data used in this project were from the CRIMSON study. To access that an email must be sent to the lead investigators of that study, available in the manuscript [ref. 13].